October 15, 2026
mayank
WhiteOak Capital Pharma and Healthcare Fund
| Fund at a Glance | |
| NAV Growth (Rs.) | 16.82 |
| NAV IDCW (Rs.) | — |
| Bonus NaV (Rs.) | — |
| Min. Investment (Rs.) | 500 |
| Min. SIP Investment (Rs.) | 100 |
| Min. No of Cheques | 6 |
| Benchmark | BSE Healthcare TRI |
| AUM Rs. | 1,003 Cr |
| (As on 30-Sep-2026) | |
| Expense | 0.53% |
| 1 Year Return (%) | 16.81 |
| 3 Year Return (%) | — |
| 5 Year Return (%) | — |
| 10 Year Return (%) | — |
| Return Since Launch | 21.57% |
Suitable For Which Investors?
Pharma funds are suitable for investors:
1. Wanting a small, supporting exposure to the pharmaceutical and healthcare sector
2. Aiming for long term wealth creation
3. With a 7+ year investment horizon, who can withstand the sharper swings of a concentrated portfolio
Note:
• Most investors can skip these funds and stick to diversified equity funds instead
• If you choose to invest, do so only through SIP
Fund’s Investment Strategy:
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Fund Manager:
1) Ramesh Mantri
Education: Mr. Mantri is an MBA, CFA and CA
Experience: Prior to joining WhiteOak Capital Mutual Fund, he has worked with WhiteOak Capital Management, Ashoka Capital Advisers, Smith Management, and CRISIL.
2) Trupti Agrawal
Education: Ms. Agrawal has done B.Com and CA.
Experience: Prior to joining WhiteOak Capital Mutual Fund, she has worked with L&T Infrastructure Finance Co. Ltd. and Ernst & Young.
3) Piyush Baranwal
Education: Mr.Piyush Baranwal is a B. Tech. in Electronics and communication from Manipal Institute of Technology,Manipal.He completed PGDBM in Finance from S.P.Jain Institute of Management and Reserch and CFA.
Experience: Prior to joining WhiteOak Capital Mutual Fund he has worked with BOI AXA, Morgan Stanley Investment Management (Jan, 2011-June, 2014) and Principal Pnb AMC as a Dealer- Fixed Income (May, 2008-Jan, 2011).
4) Dheeresh Pathak
Education: Mr. Pathak has done B.E in Electronics Engineering and a PGDBM from MDI Gurgaon
Experience: Prior to joining WhiteOak Capital Mutual Fund, he has worked with Goldman Sachs
5) Ashish Agrawal
Education: PGDBM in Finance from Institute of Management Technology, Ghaziabad and Bachelor of Commerce from University of Lucknow
Experience: Prior to joining Whiteoak Capital AMC, he was working with Motilal Owal Asset Management Co. Ltd from 2016 till date. Citigroup Global Markets Ltd from 2010 to 2016
Investment Details
| Min. Investment (Rs) | 500 |
| Min. Addl Investment (Rs) | 500 |
| Min. SIP Investment (Rs) | 100 |
| Min. Withdrawal (Rs) | 500 |
| Min. No of Cheques | 6 |
| Min. Balance (Rs) | — |
| Lock-in Period | NA |
| Exit Load | 0 |
Basic Details of WhiteOak Capital Pharma and Healthcare Fund
| Fund House | WhiteOak Capital Mutual Fund |
| Launch Date | 06-Feb-24 |
| Return Since Launch | 21.57% |
| Benchmark | BSE Healthcare TRI |
| Riskometer | Very High |
| Type | Open-ended |
| Assets | 1,003 Cr |
| (As on 30-Sep-2026) | |
| Expense | 0.53% |
| (As on 30-Sep-2026) | |
| Risk Grade | — |
| Return Grade | — |
| Turnover | 185.00% |
WhiteOak Capital Pharma and Healthcare Fund Trailing Returns (%)
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| WhiteOak Capital Pharma and Healthcare Dir | 18.98 | -0.48 | -4.85 | 0.20 | 19.29 | 16.81 | — | — | — | — |
| BSE Healthcare TRI | 11.88 | -0.17 | -4.81 | -2.18 | 15.10 | 9.74 | — | — | — | — |
| Equity: Sectoral-Pharma | 13.11 | -0.18 | -4.81 | -1.69 | 15.34 | 11.57 | — | — | — | — |
| Rank within category | 4 | 24 | 17 | 8 | 6 | 5 | — | — | — | — |
| Number of funds in category | 24 | 26 | 26 | 25 | 25 | 23 | 14 | 10 | 9 | 4 |
Peer Comparison of WhiteOak Capital Pharma and Healthcare Fund
| Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) | |
| WhiteOak Capital Pharma and Healthcare Dir | Unrated | 16.81 | — | — | 0.53 | 1,003 | 21.57 | — | 2Y 8M | 185.00 |
| ICICI Pru Healthcare Dir | 4 out of 5 stars | 3.42 | 20.58 | 15.14 | 0.89 | 6,861 | 20.02 | 1.00 (15) | 8Y 3M | 74.00 |
| SBI Healthcare Opportunities Dir | 5 out of 5 stars | 14.58 | 22.05 | 17.28 | 0.73 | 5,870 | 17.72 | 0.50 (15) | 13Y 9M | 36.00 |
| UTI Healthcare Dir | 4 out of 5 stars | 11.69 | 21.68 | 14.70 | 1.05 | 1,430 | 16.00 | 1.00 (30) | 13Y 9M | 31.00 |
| Nippon India Pharma Dir | 2 out of 5 stars | 6.83 | 16.76 | 12.78 | 0.79 | 9,166 | 17.04 | 1.00 (30) | 13Y 9M | 17.00 |
WhiteOak Capital Pharma and Healthcare Fund Portfolio Analysis
| No. of Stocks | 56 |
| Top 10 Stocks | 41.25% |
| Top 5 Stocks | 27.16% |
| Top 3 Sectors | 91.43% |
| Portfolio P/B Ratio | 7.34 |
| Portfolio P/E Ratio | 51.00 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 57,184 | 86,489 |
| Large (%) | 32.14 | 35.31 |
| Mid (%) | 24.51 | 40.58 |
| Small (%) | 43.35 | 27.23 |
Note: Mutual fund investments are subject to market risks, read all scheme-related documents carefully.
Apply Online: https://online.whiteoakamc.com/investor-login
>> Post your MF questions @ sahifund.com/ask-me/
>> NFO Guidance: https://sahifund.com/category/nfos/
Quicklinks